Semi-Annual Statement Of Income And Retained Earnings

Carna Biosciences, Inc. - Filing #7272198

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)	-34,159,000 JPY	—	-2,076,104,000 JPY	—	-2,076,104,000 JPY	—	JPY	-2,066,824,000 JPY	-2,041,945,000 JPY	-1,116,978,000 JPY	225,567,000 JPY	-1,170,402,000 JPY	-1,116,978,000 JPY	—	-1,342,546,000 JPY	—	JPY	—
Non-operating income
Non-operating income	—	—	44,097,000 JPY	—	—	—	—	43,406,000 JPY	—	—	—	3,126,000 JPY	756,000 JPY	—	—	—	—	—
Non-operating expenses
Non-operating expenses	—	—	48,732,000 JPY	—	—	—	—	48,732,000 JPY	—	—	—	9,347,000 JPY	10,061,000 JPY	—	—	—	—	—
Ordinary profit (loss)	—	—	-2,080,739,000 JPY	—	—	—	—	-2,072,150,000 JPY	—	—	—	-1,176,623,000 JPY	-1,126,283,000 JPY	—	—	—	—	—
Extraordinary losses
Extraordinary losses	—	—	93,237,000 JPY	—	—	—	—	92,569,000 JPY	—	—	—	4,562,000 JPY	4,562,000 JPY	—	—	—	—	—
Profit (loss) before income taxes	—	—	-2,173,976,000 JPY	—	—	—	—	-2,164,720,000 JPY	—	—	—	-1,181,186,000 JPY	-1,130,846,000 JPY	—	—	—	—	—
Income taxes - current	—	—	4,704,000 JPY	—	—	—	—	3,880,000 JPY	—	—	—	3,880,000 JPY	22,161,000 JPY	—	—	—	—	—
Income taxes - deferred	—	—	-104,000 JPY	—	—	—	—	-104,000 JPY	—	—	—	-113,000 JPY	-113,000 JPY	—	—	—	—	—
Profit (loss)	—	-2,168,495,000 JPY	-2,178,576,000 JPY	-2,168,495,000 JPY	—	-2,168,495,000 JPY	—	-2,168,495,000 JPY	—	—	—	-1,184,953,000 JPY	-1,152,895,000 JPY	-1,184,953,000 JPY	—	-1,184,953,000 JPY	—	-1,184,953,000 JPY